An overwhelming need
The vast and growing drug market is powered by robust fundamentals
– strong demand fueled by an aging population of solvent customers increasingly valuing health care.
Patients need and want novel drugs
- for life-threatening diseases for which there is currently no satisfactory therapy
(heart diseases, cancers, brain diseases, diabetes, orphan diseases)
- to combat against novel infectious agents
(HIV, SARS, West Nile virus, avian flu, etc.)
- for quality-of-life pathologies
(obesity, reproductive function, etc.)
- for currently-met medical needs, because of drug resistance or drug withdrawals
(antibiotics, HIV; arthritis & pain, multiple sclerosis, etc.)
Pharmaceutical companies also need to bring novel medicines
to market in order to sustain their growth, as they are losing
patent exclusivity on, and revenue
from, many of their branded drugs.
from generics firms is intensifying, and early challenges to still-valid patents are becoming increasingly frequent.